Mycobacterium abscessus is an emerging rapidly growing mycobacterium that causes tuberculous-like lesions in humans. We studied the immune control of this organism in C57BL/6 mice challenged intravenously with 10 7 CFU. Bacteria were eliminated from both the spleen and the liver within 90 days, and liver histology showed organized granulomatous lesions. A T-and B-cell requirement was investigated by challenging Rag2 ؊/؊ , Cd3 ؊/؊ , and MT ؊/؊ mice. Rag2 ؊/؊ and Cd3 ؊/؊ mice were significantly impaired in the ability to clear M. abscessus from the liver and spleen, and MT ؊/؊ mice were significantly impaired in the ability to clear M. abscessus from the liver, suggesting that infection control was primarily T cell dependent in the spleen and both T and B cell dependent in the liver. The liver granulomatous response was similar to that of wild-type controls in MT ؊/؊ mice but completely absent in Cd3 ؊/؊ and Rag2 ؊/؊ mice. We studied the involvement of gamma interferon (IFN-␥) and tumor necrosis factor (TNF) by challenging C57BL/6 mice deficient in the IFN-␥ receptor (Ifngr1 ؊/؊ ) and in TNF (Tnf ؊/؊ ). Ifngr1 ؊/؊ mice were significantly impaired in M. abscessus control both in the spleen and in the liver, and granulomas were profoundly altered. The effect was even more substantial in Tnf ؊/؊ mice; they failed to control M. abscessus infection in the liver and died within 20 to 25 days after infection with many hepatic inflammatory foci and major lesions of ischemic necrosis in the liver and kidney. These features were not observed with the closely related species M. chelonae. T-cell immunity, IFN-␥, and TNF are central factors for the control of M. abscessus in C57BL/6 mice, as they are for the control of pathogenic slowly growing mycobacteria.
Mycobacterium abscessus is a rapidly growing mycobacterium (RGM) that has emerged as a significant pathogen in humans (6, 21) following its recent recognition as a species distinct from M. chelonae (36) . M. abscessus is now recognized as the causative agent of a wide spectrum of human infections, including skin and soft tissue infections (6, 21, 54, 57) , lung infections in individuals with or without underlying disorders (e.g., cystic fibrosis) (26, 50) , and infections or pseudoinfections related to contaminated medical devices (3, 25, 57) . Disseminated infections have also been reported (11) for immunocompromised patients (organ transplantation, autoimmune disorders, malignancies) (6, 28, 48) and for subjects with a genetic defect in the interleukin-12 (IL-12)-gamma interferon (IFN-␥) signaling circuit (9) . These life-threatening infections are therapeutically problematic because M. abscessus strains are resistant to most antibiotics (6) .
In light of clinical data, M. abscessus is now considered by many authors to be one of the most pathogenic RGM species (6) . However, clear experimental evidence for its pathogenicity is poor; various studies using strains identified as M. fortuitum and M. abscessus showed that both species were lethal for mice following intravenous injection (35, 47) . Little is known about the mechanisms by which M. abscessus is controlled in a living host. Byrd and Lyons showed that severe combined immunodeficiency (SCID) mice were more susceptible to M. abscessus than wild-type mice in a pulmonary model of infection (7) . However, the roles of the B-cell and T-cell responses were not studied. The occurrence of disseminated M. abscessus infections in patients with genetic defects in the IL-12-IFN-␥ pathway implicates IFN-␥-dependent mechanisms. This is consistent with several histopathological studies in humans showing that M. abscessus can cause organized granulomatous lesions with epithelioid giant cells (53) . Recent reports of M. abscessus infection after use of inhibitors of tumor necrosis factor (TNF) (40, 52) suggested that TNF also contributes to M. abscessus control, as demonstrated for other pathogenic mycobacteria (1, 5, 38, 49) .
Using the closely related species M. chelonae as a control organism, we studied the immune control of M. abscessus in C57BL/6 mice. We show here that, in contrast to resistance to M. chelonae, resistance to M. abscessus absolutely requires adaptive immunity and that T-cell immunity, IFN-␥, and TNF have pivotal roles. T is a smooth (S) morphotype strain (10) . M. chelonae A6 was chosen on the basis of adequate growth at 35°C; type strain CIP 104535 (ϭ ATCC 35752) was unable to grow at temperatures above 32°C. Both strains were passaged twice in mice and cryopreserved at Ϫ80°C using cryobeads (Mast Diagnostics, Reinfeld, Germany). Middlebrook 7H9-0.05% Tween medium was first inoculated with a bead and grown aerobically at 35°C with orbital agitation for 72 h. Four vials containing 500 ml of Middlebrook 7H9-0.05% Tween medium were then each inoculated with 2.5 ml of the starter culture and incubated for 18 h. Each culture was harvested by centrifugation, and the pellet washed with phosphate-buffered saline (PBS), resuspended in 50 ml PBS with 10% glycerol, and dissociated by repeated passage through a 29.5-gauge needle. One-milliliter aliquots were frozen at Ϫ80°C until they were required and titrated.
Animals. Preliminary experiments comparing the course of M. abscessus infection in C57BL/6, DBA/2, and BALB/c mice showed that there was better control of bacteria in C57BL/6 mice than in the other mice in both the liver and the spleen (data not shown). We thus used mice with a C57BL/6 background for our study. Wild-type C57BL/6 mice were purchased from Elevage Janvier (Le Genest Saint-Ile, France). Knockout (KO) mice with a C57BL/6 background (recombinase activating gene 2 [Rag2 (12, 27, 34, 37, 39, 51) were purchased from Centre de Distribution, Typage et Archivage animal, Orléans, France, and age and gender matched with wild-type C57BL/6 mice. All animals were 8 to 12 weeks old when they were infected, and they were kept in a confinement class II facility under filter covers, placed in single-use cages with irradiated litter, and given irradiated chow and autoclaved water ad libidum. Experiments were conducted in accordance with the guidelines of the animal welfare committee of the Université Versailles Saint-Quentin.
Animal challenge and killing. We prepared the challenge inocula from rapidly thawed frozen aliquots. Bacterial clumps were eliminated by iterative passages through a 29.5-gauge insulin needle (Becton Dickinson), and suspensions were then diluted appropriately in PBS. Mice were inoculated by intravenous injection of 10 7 CFU in 0.2 ml into the lateral tail vein. Groups of five mice were killed at various time points by carbon dioxide narcosis, and the spleen, liver, and left lung were removed aseptically. Experiments were performed two or three times, as specified below.
Enumeration of viable bacteria. For bacterial counting, the organs were placed in 2-ml screw-cap tubes filled with sterile water and homogenized with a mini-8 beadbeater (Biospec, Bartlesville, OK) using a 5-mm stainless steel ball. Fiftymicroliter spots of serial fivefold dilutions were plated on Mueller-Hinton agar and incubated at 35°C under a humidified 5% CO 2 atmosphere for 4 days; colonies were then counted using a stereoscopic binocular microscope. The results were expressed as the mean log 10 CFU per organ. The minimum detection limits were 2 CFU per lung and 170 CFU per spleen or liver.
Histology and immunohistochemistry. Organs were fixed for 24 h by immersion in 3.7% formaldehyde, transferred to 70% ethanol for 24 to 48 h, and then embedded in paraffin. Five-micrometer-thick sections were cut with a rotary microtome, stretched in a water bath, mounted on glass slides, and stained with hematoxylin-eosin-safran (HES) or by the Ziehl-Neelsen method. Slides positive for acid-fast bacilli were included as controls for Ziehl-Neelsen staining. Qualitative analysis of the slides was carried out by an experienced pathologist (J.F.E.) blinded to the nature of the slides examined.
Liver samples to be processed for immunolabeling were embedded in OCT compound (Miles Scientific, Naperville, IL) and frozen in liquid nitrogen. Cryostat sections (thickness, 5 to 7 m) were cut, fixed in cold acetone for 10 min, and air dried. The sections were blocked with 20% goat serum in PBS for 30 min at room temperature and then incubated with 1:50 dilutions of rat primary antibody (anti-murine CD4, CD8 [eBioscience, San Diego, CA]) for 2 h at room temperature. Labeling was detected with biotinylated rabbit anti-rat immunoglobulin and neutravidin-peroxidase used according to the manufacturer's recommendations (Invitrogen, Cergy Pontoise, France). All incubations were followed by three washes in PBS. Sections were counterstained with Meyer's hematoxylin.
Flow cytometric analysis. Spleen cell suspensions were immunostained, collected on a BD-LSRII instrument (Becton Dickinson), and analyzed with FlowJo software (Tree Star Inc., United States). Anti-TCR-PE-Cy5 and anti-CD8alpha-APC-Cy7 antibodies were obtained from BD-PharMingen (BD Biosciences, Belgium), and anti-CD4-PE-Texas red was obtained from Caltag (Invitrogen, Cergy-Pontoise, France). 4Ј,6Ј-Diamidino-2-phenylindole (DAPI) (Molecular Probes, Invitrogen) was used to exclude dead cells.
Quantitative reverse transcription PCR. Total RNA was isolated from spleens with a QIAGEN RNeasy Protect mini kit with RNase-free DNase set on-column treatment (QIAGEN, Courtaboeuf, France) according to the manufacturer's instructions. An iScript reverse transcription kit (Bio-Rad, Marnes la Coquette, France) was used for reverse transcription. Quantitative PCR was carried out with a Chromo4 instrument (Bio-Rad) using qPCR MasterMix (Eurogentec) and previously described primers and 6-carboxyfluorescein-6-carboxytetramethylrhodamine double-dye oligonucleotide probes (Eurogentec, Serain, Belgium) for IFN-␥ and TNF (42) 
RESULTS
Course of M. abscessus and M. chelonae infection in C57BL/6 mice. We challenged C56BL/6 mice intravenously with 1 ϫ 10 6 , 1 ϫ 10 7 , and 5 ϫ 10 7 CFU to determine the dose best suited for analysis of the control of M. abscessus infection (Fig. 1A) . Challenge with 1 ϫ 10 7 and 5 ϫ 10 7 CFU resulted in similar liver burdens, whereas 1 ϫ 10 6 CFU induced a poorly reproducible histological response. Thus, we used the 1 ϫ 10 7 -CFU dose for comparison of M. abscessus and M. chelonae growth curves in C57BL/6 mice. We inoculated animals intravenously with each species and then counted the CFU in the lung, spleen, and liver at various times. We report below only the spleen and liver counts as the lung burden of both species remained below the threshold throughout the study. The initial distributions of mycobacteria in the liver and spleen were similar for M. abscessus and M. chelonae: about 90% of the inoculated CFU were recovered from the liver and about 10% were recovered from the spleen on day 1 (Fig. 1B) . The numbers of viable bacteria decreased similarly between days 1 and 15 for the two species, with reductions of 2 log 10 CFU in the spleen and 3 log 10 CFU in the liver. However, on day 45 postinfection, M. abscessus was still detected, whereas M. chelonae was cleared from all animals examined (Fig. 1B) , a significant difference as determined by Fisher's exact test (P Ͻ 0.03).
HES-stained liver sections from animals infected with either M. abscessus or M. chelonae had granulomas featuring a lymphocytic cuff surrounding a central core rich in macrophages, with rare epithelioid cells from day 15 on (Fig. 2) . The largest numbers, sizes, and degrees of differentiation appeared to occur on day 30, and lesions diminished by day 45 in M. abscessus-and M. chelonae-infected mice. Granulomas tended to be larger with M. abscessus than with M. chelonae as early as day 15, and this trend was constant throughout the 90 days of the experiment. Examination of lung sections showed no inflammatory reaction following inoculation with either M. abscessus or M. chelonae, as expected from the absence of bacteria detected by culture. Ziehl-Neelsen-stained slides of spleens and livers did not show evidence of acid-fast bacilli at any time.
T-and B-cell requirement for M. abscessus control. background. Rag2 Ϫ/Ϫ and Cd3ε Ϫ/Ϫ mice were severely impaired in the ability to control M. abscessus infection both in the liver and in the spleen, and the bacterial loads were significantly higher than those of the wild-type controls within 8 days after infection for Rag2 Ϫ/Ϫ mice and within 15 days for Cd3ε Ϫ/Ϫ mice ( Fig. 3) . On day 90, Cd3ε Ϫ/Ϫ and Rag2 Ϫ/Ϫ mice still harbored around 10 5 CFU in the spleen and 10 6 CFU in the liver. No death was recorded throughout the study period. The M. abscessus counts in the spleens and in the livers of MT Ϫ/Ϫ mice followed different time courses. The bacterial clearance from MT Ϫ/Ϫ mouse spleens was similar to the clearance from wild-type mouse spleens throughout the study period. In contrast, the bacterial loads in the liver were as high in MT Ϫ/Ϫ mice as in Cd3ε Ϫ/Ϫ and Rag2 Ϫ/Ϫ mice up to day 30; the load then sharply declined between day 30 and day 45, reaching the same level (ϳ10 3 CFU) as the level in wild-type controls on day 45 . Surprisingly, the CFU counts on day 90 were extremely diverse, with individual animals having counts from Ͻ170 CFU (detection limit) to Ͼ10 6 CFU; all animals appeared to be in good health. Unexpectedly, mice that were culture positive for mycobacteria on day 90 yielded colonies of the rough (R) morphotype and colonies of the original S mor- The data shown are from one of three independent experiments (means Ϯ standard deviations for log 10 and 4.2 ϫ 10 3 CFU featuring colonies of R and S morphotypes at ratios of 3/1 to 1/3. The regrowth phenomenon observed in the livers of various animals 3 months after infection was thus found to be stable over time and to be associated with the emergence of R forms.
The growth curves for M. chelonae were strikingly different. This species was almost entirely cleared from the spleen within 30 days after infection of both KO and wild-type mice, but there were differences during the first few weeks of infection. The bacterial clearance from Rag2 Ϫ/Ϫ mice was significantly worse than that from MT Ϫ/Ϫ mice, the bacterial clearance from MT Ϫ/Ϫ mice was significantly worse than that from Cd3ε Ϫ/Ϫ mice, and the bacterial clearance from Cd3ε Ϫ/Ϫ mice was significantly worse than that from wild-type mice (Fig. 3) . Bacterial clearance from the liver was complete in MT Ϫ/Ϫ mice and wild-type mice on day 90, but the liver counts were 10 4 CFU in both Cd3ε Ϫ/Ϫ mice and Rag2 Ϫ/Ϫ mice at this time point and there was no significant difference between these two KO mouse lines.
After challenge with either M. abscessus or M. chelonae, MT Ϫ/Ϫ , mice produced granulomas undistinguishable from those in wild-type controls as determined by examination of liver sections. In contrast, the histology of infected Cd3ε Ϫ/Ϫ or Rag2 Ϫ/Ϫ mice remained identical to that of uninfected controls throughout the experiment, and there was no detectable recruitment of inflammatory cells at any stage. Thus, the lack of functional T cells was associated with an absence of visible inflammatory foci during M. abscessus and M. chelonae infection. Ziehl-Neelsen staining of slides did not show mycobacteria in lymphocyte-deficient mice and in wild-type controls.
Overall, these experiments show that functional lymphocytes are absolutely required for the control of M. abscessus in C57BL/6 mice and suggest that infection control is primarily T cell dependent in the spleen and both T and B cell dependent in the liver. In contrast, the control of M. chelonae infection appears to rely mainly on innate immunity, with possible early involvement of B cells in the spleen. Functional T cells are required for complete M. chelonae clearance from the liver. (Fig. 4B) showed that M. abscessus and M. chelonae elicited similar responses; at 15 days after challenge, the transcript levels were 10 times higher than the levels in noninfected controls, and the levels returned to the baseline by day 45. Only M. abscessus elicited a significant response in the TNF mRNA level, which was three times higher on day 15 than the level in noninfected controls (P ϭ 0.012). Later in the course of the infection, on day 45, M. abscessus-infected mice had a significantly lower TNF transcript level than noninfected controls (P ϭ 0.018). The levels of TNF transcripts were significantly higher with M. abscessus than with M. chelonae (P Ͻ 0.04), and there was a significant decrease between days 15 and 45 (P Ͻ 0.01).
Roles of IFN-␥ and TNF in the control of M. abscessus. We used Ifngr1
Ϫ/Ϫ and Tnf Ϫ/Ϫ KO mice to investigate the roles of IFN-␥ and TNF. Selectively deficient mice and wild-type controls were challenged intravenously with M. abscessus or M. chelonae, and infection was followed over time by counting CFU and analyzing liver histology.
There was a significant difference between Ifngr1 Ϫ/Ϫ mice and Ifngr1 ϩ/ϩ control mice in both the spleen and the liver 15 days after challenge with M. abscessus (Fig. 5) ; the CFU counts were ϳ1 log 10 higher throughout the course of infection in the spleens and livers of Ifngr1 Ϫ/Ϫ animals, and viable bacteria had not been completely cleared from both organs 90 days after the challenge. These findings implicate involvement of IFN-␥ in both the early and later stages of infection. However, the M. abscessus load decreased steadily despite the absence of IFN-␥ signaling, hinting that there are IFN-␥-independent control mechanisms. Consistent with our previous results obtained with selectively lymphocyte-deficient mice, the spleens and livers of M. chelonae-infected Ifngr1 Ϫ/Ϫ mice responded differently (Fig. 5) . The loads in the spleen were not significantly different for the Ifngr1 Ϫ/Ϫ and Ifngr1 ϩ/ϩ mice throughout the observation period, whereas the loads in the liver were significantly higher in Ifngr1 Ϫ/Ϫ mice than in Ifngr1 ϩ/ϩ mice on days 15 and 30. M. chelonae was entirely cleared from the spleens of both Ifngr1 Ϫ/Ϫ and Ifngr1 ϩ/ϩ mice on day 90, whereas it was recovered from the livers of all but one Ifngr1 Ϫ/Ϫ mouse on day 90.
Liver histology of Ifngr1 Ϫ/Ϫ mice (Fig. 6 ) challenged with M. abscessus showed that there were inflammatory cell clumps with no macrophage-rich cores on day 15. A granulomatous architecture appeared on day 30, and there was an irregular lymphocytic cuff surrounding pigmented macrophages. The granulomas in Ifngr1 Ϫ/Ϫ mice involuted faster than those in Ifngr1 ϩ/ϩ mice and had only a few residual pigment-loaded macrophages by day 45 (Fig. 6) . (Fig. 6) . Unexpectedly, the control of M. abscessus was dramatically altered in mice deficient in TNF. Tnf Ϫ/Ϫ mice infected with M. abscessus began to die on day 20 following the intravenous challenge, whereas Tnf Ϫ/Ϫ mice receiving the same challenge of M. chelonae were asymptomatic at this time and remained healthy throughout the 90-day observation period (Fig. 7A) .
The early death of M. abscessus-infected Tnf
Ϫ/Ϫ mice prompted us to repeat our experiments with CFU determinations after 8, 15, and 21 days (Fig. 7B) . Differences in CFU counts between Tnf Ϫ/Ϫ mice and Tnf ϩ/ϩ controls were significant by day 8 in the liver and by day 15 in the spleen, and the values were ϳ2 log 10 CFU in the spleen and ϳ4 log 10 CFU in the liver on day 21 (Fig. 7B) . Moreover, M. abscessus multiplied in the livers of Tnf Ϫ/Ϫ mice between days 15 and 21 (ϳ1-log 10 CFU increase). The CFU counts in Tnf Ϫ/Ϫ and Tnf ϩ/ϩ mice were similar at all times in both the spleen and the liver (Fig. 7B) , indicating that TNF contributes little to the control of M. chelonae.
Liver histology analysis of Tnf Ϫ/Ϫ mice infected with M. abscessus showed diffuse inflammatory infiltrates evolving into pericentrolobular hepatitis during the infection (Fig. 8A, C , and E). There were apoptotic hepatocytes near the inflammatory foci on day 8 (Fig. 8B) . Hepatocyte apoptosis was not observed at later stages, and large areas of ischemic necrosis developed (Fig. 8D) . On day 21, shortly before the expected death of the mice, pathological samples showed the presence of large thrombi obtruding major vessels in the liver and kid- ney, arguing that death was at least partially due to massive thromboembolic disease (Fig. 8F) .
DISCUSSION
We report here the first detailed study of the immune control of M. abscessus in the murine host. We chose to compare M. abscessus to M. chelonae, a closely related (45) but distinct, species (36) that consistently appears to be much less frequently encountered in human infections than M. abscessus (6) . We feel that this choice was vindicated by the highly significant differences that we observed between these two species. Our results were fully consistent with a higher pathogenicity of M. abscessus (6, 56) ; in particular, adaptive immunity was essential for the murine host to control M. abscessus infection, whereas M. chelonae control appeared to be much easier and mainly dependent on innate immunity. As observed for intravenous challenge with M. smegmatis (46) , 90% of the bacteria were localized in the liver and only 10% were localized in the spleen. In contrast to several clinical reports (6, 26, 50), we did not find any particular ability of M. abscessus to become established in the lungs. We were unable to recover M. abscessus and M. chelonae from lung tissue after intravenous challenge, and neither species caused detectable lung tissue lesions. By comparison, intravenous challenge of mice with M. tuberculosis or M. avium initially leads to bacterial growth in the lungs, spleen, and liver during the first few weeks after challenge, and there is spontaneous resolution in all organs but the lungs (15, 17, 20) ; such M. tuberculosis infections are ultimately lethal (17) . Our findings are consistent with a previous report that it is impossible to induce a true M. abscessus lung infection by challenging immunocompetent mice by the intratracheal route (7). Our findings are also in line with the occurrence of M. abscessus lung disease in patients with preexisting lesions of the respiratory tract (e.g., cystic fibrosis or bronchiectasis). This suggests that more appropriate animal models mimicking clinical situations (e.g., cystic fibrosis) should be used to investigate the mechanisms of M. abscessus lung infection.
The role of adaptive immunity in the control of slowly growing mycobacteria (SGM) has been widely studied in intrave- nous infection models using SCID mice and mice selectively deficient in RAG. The growth of virulent M. tuberculosis strains in the spleen, liver, and lungs of SCID mice following intravenous challenge is exponential. The growth of M. bovis BCG is slower but still progressive, whereas growth of the attenuated M. tuberculosis strain H37Ra is controlled in both SCID and wild-type mice (41) . Virulent strains of M. avium behave identically in the spleens of SCID and wild-type C57BL/6 mice for the first few weeks of infection. However, the bacterial counts in the spleens of SCID mice continue to increase after 8 weeks of infection, by which time the counts begin to decline in wild-type C57BL/6 mice (15). As observed for M. tuberculosis complex (41) Ϫ/Ϫ , Cd3ε Ϫ/Ϫ and MT Ϫ/Ϫ KO mice clearly showed that control of M. abscessus infection relies primarily on T-cell immunity, a finding which has been abundantly documented for SGM (22) . Indeed, Cd3ε
Ϫ/Ϫ and Rag2 Ϫ/Ϫ mice are both severely impaired in the ability to clear M. abscessus infection; bacterial loads persist 3 months after challenge (ϳ10 5 CFU in the spleen and ϳ10 6 CFU in the liver for both types of KO mice), whereas bacteria have been cleared from wild-type mice by that time. The involvement of T-cell immunity was also supported by our analysis of the splenic T-cell response during M. abscessus infection, with generation of a TCR ϩ CD4 ϩ cellular response on day 15. Although our study is the first study to establish the T-cell dependence of the immune response to an RGM species, it has not been demonstrated that this trait is unique to M. abscessus. We showed that an M. chelonae control was largely unaffected by the loss of T-cell function, especially in the spleen. This suggests that the behavior of M. abscessus differs from that of other RGM species. However, other studies including more RGM species would have to be performed to clarify this issue.
B-cell immunity plays a minor role compared to the role of T-cell immunity, but it is nonetheless involved in the early control of SGM infections in the mouse. It has been shown that MT Ϫ/Ϫ mice challenged intravenously with 10 6 CFU of M. tuberculosis or M. bovis BCG had eightfold-higher bacterial counts than wild-type controls up to 6 weeks postinfection, although there were no significant differences between the two mouse lines at later times (55) . Studies using respiratory challenge with M. tuberculosis have failed to provide evidence of any consistent growth difference, but B cells appear to facilitate dissemination outside the lung and to mitigate the severity of pathological lesions (4, 29) . In contrast to observations with SGM, we found that the ability of MT Ϫ/Ϫ mice to control M. abscessus was highly abnormal; the abnormality involved only the liver, where the bacterial loads were 100 times higher than those in wild-type controls on days 15 and 30 postinfection. Bacterial loads in the spleen were similar in MT Ϫ/Ϫ mice and wild-type controls, arguing against a major role for B cells in this organ. However, the observation that there were significantly higher loads in the spleens of Rag2 Ϫ/Ϫ mice than in the spleens of Cd3ε Ϫ/Ϫ mice at the early stages indicates that there may be B-cell-mediated control in the spleen. This effect is unmasked in the spleen only in the absence of the much more potent T-cell-mediated immunity, as hinted at by comparative analysis of bacterial growth curves in MT Ϫ/Ϫ and Cd3ε
The mechanisms by which B cells may affect the course of mycobacterial infections are believed to involve enhanced antigen presentation, Th1-Th2 bias of the T-cell response, or opsonizing or neutralizing antibodies directed against bacteria or bacterial products (8) . Any of these mechanisms may be involved in the case of M. abscessus. It is, however, puzzling that R-morphotype variants of M. abscessus were found only in MT Ϫ/Ϫ mice. R variants from M. abscessus CIP 104536 T have recently been shown to have lost the ability to produce glycopeptidolipids (GPLs) (10) . The emergence of such R variants in MT Ϫ/Ϫ mice thus suggests that GPLs are major targets of B-cell-mediated immunity to M. abscessus. GPLs can make up as much as 70% of the lipids exposed at the mycobacterial surface (2) and have been shown to elicit production of high antibody levels during mycobacterial infections in humans (33) . Although our results clearly show the importance of Bcell-mediated immunity for M. abscessus control, we must emphasize that they were obtained in an intravenous challenge model with a large bacterial inoculum. Consequently, these findings are in no way predictive of the role of B cells in models with smaller challenge doses or with other routes of administration. It is similarly difficult to extrapolate our results to humans, all the more so because we have no knowledge of any report of M. abscessus infection in the context of a humoral deficit.
The role of IFN-␥ in antimycobacterial immunity is different in different mycobacterial species, as judged by studies using mice deficient in either IFN-␥ or IFN-␥ receptor (13, 23) .
Ifngr1
Ϫ/Ϫ mice are highly susceptible to M. bovis BCG and die within 9 weeks of a challenge (30) . The course of infection is for the most part similar to that in wild-type controls during the first few weeks, but mycobacteria then grow unrestrictedly in Ifngr1 Ϫ/Ϫ mice, following the same pattern that is observed in SCID mice (41) . Data for M. avium during the chronic stage of infection also suggest that IFN-␥ has a major role, with unrestrained mycobacterial growth but no reported lethality 11 weeks postinfection in IFN-␥-deficient mice (15) . Ehlers and Richter classified 13 recently described nontuberculous mycobacteria on the basis of their behavior in IFN-␥-deficient mice and isogenic BALB/c controls as follows: (i) bacteria growing in the spleens of both IFN-␥-deficient and wild-type mice; (ii) bacteria eliminated from wild-type mice but growing in IFN-␥-deficient mice; and (iii) bacteria eliminated even from IFN-␥-deficient mice (20) . Only one RGM, M. confluentis, was assayed and was shown to be cleared from the spleens of both wild-type and IFN-␥-deficient mice within 4 weeks (20 (14, 43) . However, such individuals are much more frequently infected with vaccinal M. bovis BCG or with M. avium (16) .
We were surprised by the major defect in M. abscessus control affecting Tnf Ϫ/Ϫ mice; these mice showed clear bacterial regrowth between days 15 and 21 in the liver, and all animals died within 30 days after the challenge. These results are highly relevant because TNF-deficient mice infected with M. chelonae were asymptomatic and the bacterial counts were not significantly different from those in wild-type controls. Similar bacterial counts were obtained in TNF-deficient mice infected intravenously with M. chelonae (this study) and M. smegmatis (46) . This is consistent with the absence of a significant TNF response in M. chelonae-infected mice. The only previous descriptions of severe experimental mycobacterial pathogenesis caused by disruption of the TNF pathway involved infections with SGM. Mice selectively deficient in TNFRp55 and intravenously challenged with 5 ϫ 10 5 CFU of M. tuberculosis died within 3 weeks after the challenge (24); similar results were subsequently reported for TNF-deficient mice (31) . The profile of M. avium infection is closer to that of the M. abscessus model, with survival of IFN-␥-deficient animals, death of mice deficient in TNF signaling (TNFRp55 deficient) within a similar time, and bacterial loads otherwise compatible with survival (19) . This is consistent with clinical observations; M. avium and M. abscessus have been reported to cause infections in patients receiving TNF inhibitor therapies (40, 52) . TNF plays an important role in the control of mycobacterial growth in tissues by contributing to the early organization and maintenance of the granuloma (46) . However, the control of mycobacterial growth in itself cannot explain the lethality observed with M. abscessus and M. avium, because the bacterial loads at the time of death in TNF-and TNFRp55-deficient mice are lower than the bacterial loads compatible with life in other selectively deficient or wild-type mice (18) . It has been reported by Ehlers et al. that death of TNFRp55-deficient mice infected with M. avium was caused not by an increased mycobacterial load but by acute granuloma disintegration and destruction of the surrounding tissues (19) , a finding consistent with our results. Major thromboembolic lesions may also contribute to the death of animals, as suggested by our premortem pathological observations. However, the histological results of TNF-deficient mouse studies should be interpreted with care, given the potential alterations in tissue architecture in these mice.
Overall, we show here that the immune control of M. abscessus exhibits characteristics previously observed in experimental infections with SGM, particularly M. avium. Our study confirms the unusual position of M. abscessus among the RGM (44) and raises questions about the molecular mechanisms involved in the virulence of this species. We are currently sequencing the entire genome of M. abscessus CIP 104536 T , which should allow decisive progress. Another interesting issue is the dynamics underlying the S-morphotype/R-morphotype variation during infection of a live host by M. abscessus. Work is also in progress to address this question.
